Over the last 15 years, Dr. Boles has been a paid advisor in some capacity in 4 different
genetic/DNA laboratories, including University Children’s Genetic Laboratory (Progene),
Medomics, Courtagen, and Lineagen. In particular, Dr. Boles was the Medical Director of
Courtagen from 2012 to 2017. Courtagen pioneered the use of massive DNA sequencing in
multifactorial, neurodevelopmental, and functional conditions, demonstrating to many that this
amazing new technology can improve medical care for many. However, insurance companies did
not see it that way, and poor insurance reimbursement led to the closure of the DNA laboratory
in the summer of 2017. Insurance denial have led to the closure of many genetic laboratories in
this new and cutthroat industry. For a few months following Courtagen, Dr. Boles was an
Advisor for Lineagen, an arrangement that ended in the winter of 2018.
Science and technology have advanced substantially in the last year, and the power of genetic
testing now far exceeds that which was then state-of-the-art during Courtagen’s time. At present,
Dr. Boles does not work for, and is not paid by, any laboratory. However, he works with several
laboratories in order to ensure the optimal testing for each patient that he follows or advises on.
The process is complex, and for more information, see the question and answer found in the FAQ Section.
At the current time, Dr. Boles orders testing from Variantyx. Of course,
some patients come to see Dr. Boles with test results from other laboratories. The usefulness of
these reports depends greatly on the exact tests performed and the capabilities and report
characteristics of the laboratory.